Skip to main content
. 2020 Mar 13;8(1):126. doi: 10.3390/vaccines8010126

Figure 2.

Figure 2

Percentage of MBCs producing H3N2v-specific IgG at baseline (Day 0) correlates with Day 8 H3N2v-specific plasmablast response (A: IgA and B: IgG).